(E)-ETHYL 3-(PYRIDIN-2-YL)ACRYLATE, 95.0%, 1g

Methyl4-chloro-2-oxo-1,3-dihydropyrrolo[2,3-b]pyridine-5-carboxylate, 98%, 250mg

Methanesulfonato(2-dicyclohexylphosphino-3,6-dimethoxy-2',4',6'-tri-i-propyl-1,1'-biphenyl)(2'-amino-1,1'-biphenyl-2-yl)palladium(II), 98%, 10g

Pyrrolidine, 2-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]diphenylmethyl]-, (2R)-, 98%, 10g

1-Bromo-4-(difluoromethyl)-2-fluorobenzene, 97.0%, 1g

7-Bromobenzo[c][1,2,5]thiadiazole-4-carbaldehyde, 97.0%, 1g

Objectif IOS Plan PLi S60x/0,85 corrigé à l'infini. Distance de travail 0,46 mm

3-(5-tert-Butyl-1,2,4-oxadiazol-3-yl)piperidine hydrochloride, 1g

Methyl 5-fluoro-3-methylpicolinate, 95.0%, 1g

Methyl 4-acetamido-5-chloro-2,3-dihydrobenzofuran-7-carboxylate, 95.0%, 250mg

Tri-tert-butyl 1,4,7,10-Tetraazacyclododecane-1,4,7-triacetate Hydrobromide, 97%, 5g

2-(2-chlorophenyl)acetophenone, 97.0%, 250mg

Ethyl 7-bromoisoquinoline-3-carboxylate, 95.0%, 100mg